Image

Global Circulating Tumor Cells (CTC) Liquid Biopsy Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 134
  • No of Figures: 63

Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, By Technology (CTC Detection Methods, CTC Enrichment Methods, Ex Vivo Positive Selection, Molecular (RNA)-Based Technologies, Functional In vitro Cell Invasion Assay, Xenotransplantation Models, Microchips, Single Spiral Microchannel, Negative Selection & Immunocytochemical Technologies), Application (Cancer Stem Cell Research, Multiple Chromosome Abnormalities & Others), End User (Research & Academic Institutes, Reference Laboratories & Hospitals & Physician Laboratories), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan,  China, South Korea, India, Australia, Singapore,  Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa) - Industry Trends and Forecast to 2029

Circulating Tumor Cells (CTC) Liquid Biopsy Market Market Analysis and Insights: Global Circulating Tumor Cells (CTC) Liquid Biopsy Market

Global circulating tumor cells (CTC) liquid biopsy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 25.3% in the forecast period of 2022 to 2029 and is expected to reach USD 5,756.44 million by 2029 from USD 1,001.83 million in 2021. The high prevalence of chronic diseases and increasing R&D activities for its effective application is likely to be the major drivers which propel the demand of the market in the forecast period.

The liquid biopsy is a non-invasive blood test which detects circulating tumor cells and tumor DNA fragments which are released into the blood from primary tumors and metastatic sites. It is a simple and precise alternative to surgical biopsy procedure, which allows surgeon to detect cancer at a very early stage.

The circulating tumor cells are a rare sub-set of cells which function as a seed of metastases. It is found in blood of patients who have developed solid tumors. The testing of circulating tumor cells allows the detection and quantification of tumor cells in the blood of cancer patients. The various types of biological phenotypes of circulating tumor cells (CTCs) exits includes stem cell-like or mixed, mesenchymal or epithelial. These phenotypes are present in blood in a very small quantity. Due to which, their detection needs a phase of isolation-enrichment. After that, a second phase of detection.

The growing demand of circulating tumor cells (CTC) liquid biopsy because of their efficacy, high prevalence of cancer are the major drivers propelling the demand for circulating tumor cells (CTC) liquid biopsy market in the forecast period. However, the unclear regulatory and reimbursement scenario, shortage of skilled personnel is restraining the circulating tumor cells (CTC) liquid biopsy market growth in the forecast period.  

The global circulating tumor cells (CTC) liquid biopsy market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Circulating Tumor Cells (CTC) Liquid Biopsy Market Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope and Market Size

Global circulating tumor cells (CTC) liquid biopsy market is categorized into three notable segments which are based on technology, application and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

  • On the basis of technology, global circulating tumor cells (CTC) liquid biopsy market is segmented into CTC detection methods, CTC enrichment methods, ex vivo positive selection, molecular (RNA)-based technologies, functional in vitro cell invasion assay, xenotransplantation methods, microchips, single spiral microchannel, negative selection and immunocytochemical technologies  In 2021, CTC detection methods segment is expected to dominate the market because of increasing use of this technology in the academics and research centers for the tests of liquid biopsy.
  • On the basis of application, global circulating tumor cells (CTC) liquid biopsy market is segmented into cancer stem cell research, multiple chromosome abnormalities and others. In 2021, cancer stem cell research segment is expected to dominate the market because of increasing demand of early diagnosis and treatment of cancer.
  • On the basis of end user, global circulating tumor cells (CTC) liquid biopsy market is segmented into research and academic institutes, reference laboratories and hospitals and physician laboratories. In 2021, academic and research institutes segment is expected to dominate the market because of research and academic institutes perform an essential role to accelerate research and development in the various therapeutic area related to liquid biopsies.

Circulating Tumor Cells (CTC) Liquid Biopsy Market Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Country Level Analysis

The global circulating tumor cells (CTC) liquid biopsy market is analysed and market size information is provided by country, technology, application and end user.

The countries covered in the global circulating tumor cells (CTC) liquid biopsy market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Lithuania, rest of Europe in Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific(APAC) Brazil, Argentina, Peru, rest of South America in South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait and rest of Middle East and Africa in Middle East and Africa (MEA).

The U.S. is dominating the global circulating tumor cells (CTC) liquid biopsy in the North American region due to rise in number of cancer patients and presence of major players in the market. Whereas, Germany is dominating the circulating tumor cells (CTC) liquid biopsy market in the European region due to presence of untapped opportunities in Germany and growing geriatric population in Germany. Additionally, China is dominating the circulating tumor cells (CTC) liquid biopsy maket in the Asia Pacific region due to increased awareness regarding the early diagnosis and treatment of diseases such as cancer and increasing healthcare expenditure which leads to improvement in diagnostic rate.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Technological Development along with Public-Private Funding are Creating Opportunities in the Global Circulating Tumor Cells (CTC) Liquid Biopsy Market  

Global circulating tumor cells (CTC) liquid biopsy market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the market, changes in regulatory scenarios with their support for the circulating tumor cells (CTC) liquid biopsy market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Global Circulating Tumor Cells (CTC) Liquid Biopsy Share Analysis

The circulating tumor cells (CTC) liquid biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the circulating tumor cells (CTC) liquid biopsy market.

The major companies which are dealing in the global circulating tumor cells (CTC) liquid biopsy market are Eurofins Genomics ( a subsidiary of Eurofins Scientific), MDx Health, Guardant Health, IMMUCOR, Thermo Fisher Scientific, Inc., Menarini Silicon Biosystems, QIAGEN, Exact Sciences Corporation, Myriad Genetics, Inc., LungLife AI, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc. , Natera Inc.,  ExoDx ( a subsidiary of Bio-Techne Corporation), Biocept, Inc., F. Hoffman-La Roche Ltd. ,FOUNDATION MEDICINE, INC., Lucence Health, Inc., Inivata Ltd, Biolidics Limited, Vortex Biosciences among others.

For instance,

  • In November 2021, Myriad Genetics, Inc. announced that it has presented the data at San Antonio Breast Cancer Symposium and highlighted the value of genetic testing in breast cancer treatment. This will help the company to advance the launch of novel product in the market.
  • In February 2021, Menarini Silicon Biosystems announced the launch of CellMag product line for manual enrichment and staining of circulating tumor cells. This has helped the company to increase its product line.

Collaboration, joint ventures, and other strategies by the market player is enhancing the company market in the circulating tumor cells (CTC) liquid biopsy market, which also provides the benefit for the organization to improve their offering for circulating tumor cells (CTC) liquid biopsy market.

Customization Available: Global Circulating Tumor Cells (CTC) Liquid Biopsy Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL CTC DETECTION METHODS IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL CTC ENRICHMENT METHODS IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL EX VIVO POSITIVE SELECTION IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL MOLECULAR (RNA)-BASED TECHNOLOGIES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL FUNCTIONAL IN VITRO CELL INVASION ASSAY IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL XENOTRANSPLANTATION MODELS IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL MICROCHIPS IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 GLOBAL SINGLE SPIRAL MICROCHANNEL IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL NEGATIVE SELECTION IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL IMMUNOCYTOCHEMICAL TECHNOLOGIES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL CANCER STEM CELL RESEARCH IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL MULTIPLE CHROMOSOME ABNORMALITIES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL OTHERS IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL RESEARCH & ACADEMIC INSTITUTES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL REFERENCE LABORATORIES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL HOSPITALS AND PHYSICIAN LABORATORIES IN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 25 U.S. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 26 U.S. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 27 U.S. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 28 CANADA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 29 CANADA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 CANADA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 31 MEXICO CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 32 MEXICO CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 33 MEXICO CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 34 EUROPE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 35 EUROPE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 36 EUROPE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 37 EUROPE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 GERMANY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 39 GERMANY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 40 GERMANY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 41 FRANCE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 42 FRANCE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 FRANCE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 44 U.K. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 45 U.K. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 46 U.K. CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 47 ITALY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 48 ITALY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 ITALY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 RUSSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 51 RUSSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 52 RUSSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 53 SPAIN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 54 SPAIN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 SPAIN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 TURKEY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 57 TURKEY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 58 TURKEY CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 59 NETHERLANDS CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 60 NETHERLANDS CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 NETHERLANDS CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 62 SWITZERLAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 63 SWITZERLAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 SWITZERLAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 65 BELGIUM CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 66 BELGIUM CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 BELGIUM CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 68 REST OF EUROPE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 69 ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 70 ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 71 ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 72 ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 73 CHINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 74 CHINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 CHINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 76 JAPAN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 77 JAPAN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 78 JAPAN CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 79 INDIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 80 INDIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 81 INDIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 82 SOUTH KOREA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 83 SOUTH KOREA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 SOUTH KOREA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 AUSTRALIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 86 AUSTRALIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 AUSTRALIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 88 SINGAPORE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 89 SINGAPORE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 SINGAPORE CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 91 THAILAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 92 THAILAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 THAILAND CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 94 MALAYSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 95 MALAYSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 96 MALAYSIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 INDONESIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 98 INDONESIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 99 INDONESIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 PHILIPPINES CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 101 PHILIPPINES CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 102 PHILIPPINES CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 103 REST OF ASIA-PACIFIC CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 104 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 105 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 106 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 108 BRAZIL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 109 BRAZIL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 BRAZIL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 111 ARGENTINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 112 ARGENTINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 ARGENTINA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 114 REST OF SOUTH AMERICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 115 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 116 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 117 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 118 MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 SOUTH AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 120 SOUTH AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 121 SOUTH AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 122 SAUDI ARABIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 123 SAUDI ARABIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 124 SAUDI ARABIA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 125 U.A.E CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 126 U.A.E CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 127 U.A.E CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 128 EGYPT CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 129 EGYPT CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 EGYPT CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 131 ISRAEL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 132 ISRAEL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 ISRAEL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 134 REST OF MIDDLE EAST AND AFRICA CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions